Want to join the conversation?
$AGN's U.S. Brands net revenues for 1Q16 increased by 27% to $2.3Bil from last year. Growth was mainly attributed to the acquisition of legacy Allergan products. Net segment contribution for 1Q16 increased 33% over the prior year period to $1.5Bil primarily as a result of the Allergan acquisition.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?